BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22

• Press Releases

  Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs

  July 11, 2025

   · 

  12 min read
• Press Releases

  Pelthos Therapeutics Launches ZELSUVMI™ (berdazimer) Topical Gel 10.3%, the First and Only FDA-Approved At-Home Treatment for Molluscum Contagiosum

  July 11, 2025

   · 

  8 min read
• Press Releases

  Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease

  July 11, 2025

   · 

  6 min read
• Press Releases

  CS Genetics Launches 96-Sample SimpleCell™ Kit, Delivering Same-Day Single Cell RNA-Seq at Population Scale

  July 11, 2025

   · 

  2 min read
• Press Releases

  Kodiak Sciences to Host Investor R&D Day on July 16, 2025

  July 11, 2025

   · 

  2 min read
• Press Releases

  PDS Biotech Announces Colorectal Cancer Cohort of Phase 2 Clinical Trial with PDS01ADC Met Criteria for Expansion to Stage 2 Following Positive Stage 1 Results

  July 11, 2025

   · 

  7 min read
• Press Releases

  Biogen and Stoke Therapeutics Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS) Congress

  July 11, 2025

   · 

  13 min read
• Press Releases

  Acumen Pharmaceuticals to Present Studies on Cost Savings Associated with Use of pTau217 Screening Assay in Phase 2 ALTITUDE-AD Study and Sabirnetug Oligomer-Selectivity at the Alzheimer’s Association International Conference (AAIC®) 2025

  July 11, 2025

   · 

  5 min read
• Press Releases

  AbbVie and Ichnos Glenmark Innovation (IGI) Announce Exclusive Global Licensing Agreement for ISB 2001, a First-in-Class CD38×BCMA×CD3 Trispecific Antibody

  July 11, 2025

   · 

  7 min read
• Press Releases

  Cognition Therapeutics Completes End-of-Phase 2 Meeting with FDA for Zervimesine (CT1812) in Alzheimer’s Disease

  July 11, 2025

   · 

  7 min read